Glucose intolerance in Chinese patients with chronic hepatitis C

被引:17
作者
Chen, LK
Hwang, SJ
Tsai, ST
Luo, JC
Lee, SD
Chang, FY
机构
[1] Taipei Vet Gen Hosp, Dept Family Med, Dept Med, Taipei 11217, Taiwan
[2] Natl Yang Ming Univ, Sch Med, Taipei 112, Taiwan
[3] Taipei Vet Gen Hosp, Dept Med, Div Gastroenterol, Taipei 11217, Taiwan
[4] Taipei Vet Gen Hosp, Dept Med, Div Endocrinol Diabet & Metab, Taipei 11217, Taiwan
关键词
D O I
10.3748/wjg.v9.i3.505
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
AIM: To investigate the prevalence and the risk factors of glucose intolerance in Chinese patients with chronic hepatitis C and to evaluate the relationship between interferon (IFN) treatment and glucose intolerance in these patients. METHODS: Prospective cross-sectional study was done to evaluate the prevalence of glucose intolerance in Chinese patients with chronic hepatitis C virus (HCV) infection from the outpatient clinic of Department of Family Medicine, Taipei Veterans General Hospital. Chronic hepatitis C was defined as persistent presence of anti-HCV and persistent elevation of liver transaminase for at least 1.5 folds for at least 6 months. Moreover, patients were further categorized into normal fasting glucose and glucose intolerance (diabetes mellitus (DM) and impaired fasting glucose) according to the diagnostic criteria of American Diabetic Association. RESULTS: Totally, 359 Chinese patients with chronic hepatitis C were enrolled (212 males and 147 females, mean age=58.1 +/- 13.0 years). One hundred and twenty-three patients (34.3%) had received various forms of IFN treatment. One hundred and twenty-five patients (34.6%) had glucose intolerance, including 99 patients (27.6%) with DM and 26 patients (7.0%) with impaired fasting glucose. In comparison with those with normal fasting glucose levels, patients with chronic hepatitis C with glucose intolerance were significantly older, had a significantly higher body mass index, and they were more likely to suffer from obesity, to have family history of diabetes and to have had previous IFN treatment. Stepwise multivariate logistic regression revealed significantly that age greater than or equal to57 years, obesity, previous history of IFN treatment and the presence of family history of diabetes were independent risk factors associated with the presence of glucose intolerance in chronic hepatitis C patients. CONCLUSION: In conclusion, 34.6% of Chinese patients with chronic hepatitis C had glucose intolerance. Chronic hepatitis C patients who were older in age, obese, had previous IFN treatment history and had family history of diabetes were prone to develop glucose intolerance. To our knowledge, this is the first population-based report to confirm that interferon treatment to be an independent risk factor to develop glucose intolerance.
引用
收藏
页码:505 / 508
页数:4
相关论文
共 39 条
[1]   EVIDENCE FOR A LINK BETWEEN HEPATITIS-C VIRUS-INFECTION AND DIABETES-MELLITUS IN A CIRRHOTIC POPULATION [J].
ALLISON, MED ;
WREGHITT, T ;
PALMER, CR ;
ALEXANDER, GJM .
JOURNAL OF HEPATOLOGY, 1994, 21 (06) :1135-1139
[2]   Autoimmunity against pancreatic islets and other tissues before and after interferon-α therapy in patients with hepatitis C virus chronic infection [J].
Betterle, C ;
Fabris, P ;
Zanchetta, R ;
Pedini, B ;
Tositti, G ;
Bosi, E ;
de Lalla, F .
DIABETES CARE, 2000, 23 (08) :1177-1181
[3]   Hepatitis C-related cirrhosis: A predictor of diabetes after liver transplantation [J].
Bigam, DL ;
Pennington, JJ ;
Carpentier, A ;
Wanless, IR ;
Hemming, AW ;
Croxford, R ;
Greig, PD ;
Lilly, LB ;
Heathcote, JE ;
Levy, GA ;
Cattral, MS .
HEPATOLOGY, 2000, 32 (01) :87-90
[4]   Rapidly reversible increase in insulin requirement with interferon [J].
Campbell, S ;
McLaren, EH ;
Danesh, BJ .
BRITISH MEDICAL JOURNAL, 1996, 313 (7049) :92-92
[5]  
Carithers Jr RL, 1997, HEPATOLOGY S1, V26, p83S
[6]   Further evidence for an association between non-insulin-dependent diabetes mellitus and chronic hepatitis C virus infection [J].
Caronia, S ;
Taylor, K ;
Pagliaro, L ;
Carr, C ;
Palazzo, U ;
Petrik, J ;
O'Rahilly, S ;
Shore, S ;
Tom, BDM ;
Alexander, GJM .
HEPATOLOGY, 1999, 30 (04) :1059-1063
[7]   Epidemiologic study of type 2 diabetes in Taiwan [J].
Chang, CJ ;
Lu, FH ;
Yang, YC ;
Wu, JS ;
Wu, TJ ;
Chen, MS ;
Chuang, LM ;
Tai, TY .
DIABETES RESEARCH AND CLINICAL PRACTICE, 2000, 50 :S49-S59
[8]   Insulin-dependent diabetes mellitus during alpha-interferon therapy for chronic viral hepatitis [J].
Fabris, P ;
Betterle, C ;
Greggio, NA ;
Zanchetta, R ;
Bosi, E ;
Biasin, MR ;
de Lalla, F .
JOURNAL OF HEPATOLOGY, 1998, 28 (03) :514-517
[9]  
FARRELL GC, 1997, HEPATOLOGY S1, V26, P96
[10]   A survey of adverse events in 11241 patients with chronic viral hepatitis treated with alfa interferon [J].
Fattovich, G ;
Giustina, G ;
Favarato, S ;
Ruol, A ;
Macarri, G ;
Orlandi, F ;
Iaquinto, G ;
Ambrosone, L ;
Francavilla, A ;
Pastore, G ;
Santantonio, MT ;
Romagno, D ;
Bolondi, L ;
Sofia, S ;
Marchesini, A ;
Pisi, E ;
Mazzella, G ;
Roda, E ;
Attaro, L ;
Chiodo, F ;
Mori, F ;
Verucchi, G ;
Lanzini, A ;
Salmi, A ;
Calvi, B ;
Bozzetti, F ;
Radaeli, E ;
Bernasconi, M ;
Pilleri, G ;
Bacca, D ;
Romano, G ;
Mastrapasqua, G ;
Cozzolongo, R ;
Cacopardo, B ;
Nunnari, A ;
Blasi, A ;
Sala, LO ;
Minoli, G ;
Sangiovanni, A ;
Spinzi, GC ;
Colombo, A ;
Camassa, M ;
Riva, D ;
Maggi, G ;
Boccia, S ;
Gualandi, G ;
Nucci, A ;
Pacini, F ;
Marino, N ;
Mazzotta, F .
JOURNAL OF HEPATOLOGY, 1996, 24 (01) :38-47